007370 — Jin Yang Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual income statement for Jin Yang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	49,525	62,839	76,264	94,111	113,332
Cost of Revenue
Gross Profit	26,282	33,984	45,651	57,459	69,884
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	45,264	55,876	64,800	84,816	101,897
Operating Profit	4,261	6,964	11,464	9,295	11,435
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,533	12,132	14,535	12,583	37,054
Provision for Income Taxes
Net Income After Taxes	5,229	9,538	12,308	12,659	29,694
Net Income Before Extraordinary Items
Net Income	5,229	9,538	12,308	12,659	29,694
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	5,229	9,622	12,309	12,660	29,384
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	468	842	894	1,004	2,406
Dividends per Share